查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631563

全球数位神经生物标记市场：市场规模、份额和趋势分析（按类型、临床程序、最终用途、地区和细分，2025-2030 年）

Digital Neuro Biomarkers Market Size, Share & Trend Analysis Report By Type (Wearable, Mobile based Applications), By Clinical Practice, By End Use, By Region, and Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

数位神经生物标记市场的成长和趋势：

预计到 2030 年全球数位神经生物标记市场规模将达到 28.2 亿美元，2025 年至 2030 年期间的复合年增长率为 25.7%。

由于神经系统疾病盛行率不断上升、全球老年人口不断增长、技术进步、个人化医疗需求以及私人和上市公司对市场的投资不断增加等多种因素，市场正在经历显着增长。此外，扩大对数位健康技术的监管核准和报销正在推动数位神经生物标记的采用。监管机构已经认识到这些技术改善患者治疗效果的潜力，并制定了支持性政策和报销模式。

阿兹海默症、帕金森氏症和多发性硬化症等神经系统疾病的发生率不断上升，大大推动了对数位神经生物标记的需求。这些复杂的疾病需要准确、持续的监测和早期检测，以有效控制症状并改善患者的治疗效果。数位神经生物标记透过穿戴式感测器和行动医疗应用等先进技术精确追踪神经功能和疾病进展。透过提供即时资料和见解，这些生物标记可以实现早期疗育和个人化治疗策略，满足及时和有针对性地管理神经系统疾病的迫切需求。例如，多发性硬化症（MS）影响了美国近一百万人。根据美国多发性硬化症协会的数据，估计全球整体有超过 280 万人患有多发性硬化症。多发性硬化症最常在 20 至 50 岁之间诊断出来，但它可以发生在任何年龄。女性患有 MS 的几率也高于男性。

人们越来越重视神经系统疾病的早期发现和预防。数位神经生物标记的优势在于能够比传统方法更早检测出疾病标记物，从而能够及时干预和管理。人工智慧和机器学习的整合也在推动市场成长；例如，2022 年 9 月，Nutromics 从 Dexcom Ventures 获得了 1400 万美元的资金，以推进其「实验室贴片」平台。这项创新技术利用 DNA 感测器来监测各种目标，包括疾病生物标记和具有挑战性的治疗药物。此外，将数位神经生物标记与更广泛的数位健康平台（如电子健康记录（EHR）和远端医疗）相结合，将提高其效用和可访问性。这种整合有利于持续监测和即时资料分析，从而改善患者护理和治疗结果。例如，2021年10月，致力于开发先进神经系统疾病诊断技术的人工智慧公司Altoida启动了一项为期五年的多中心观察性研究。这项广泛的研究将涉及阿兹海默症各个阶段的数千名患者，旨在了解疾病的连续性并提高诊断能力。

主要企业正在采用合併、收购和产品发布等各种策略来保持竞争力。主要市场参与企业的关键策略倡议包括：

  • 2024 年 4 月，Tris Pharma Inc. 与 Braingaze Ltd. 签订授权合约，成立 Tris Digital Health。新部门将专注于开发和销售针对注意力不足过动症（ADHD）和其他神经系统疾病的数位诊断和治疗产品。
  • 2024 年 3 月，Cumulus Neuroscience 获得了 Innovate UK SBRI（小型企业研究计画）约 125 万美元的津贴。这笔资金将用于支持旨在提高血液生物标记准确性的人工智慧诊断工具的开发和检验。新的 AI 演算法将血液生物标记与透过 Cumulus Neuroassessment Platform 获得的数位生物标记和人口统计资讯相结合。
  • 2024年1月，哈佛大学约翰‧保尔森工程与应用科学学院、波士顿大学萨金特健康与復健科学学院和哈佛大学维斯研究所的研究人员开发出一种柔软的穿戴式机器人，旨在帮助帕金森氏症患者更顺畅地行走。这款创新的机器人服装穿在大腿和臀部周围，每次腿部摆动都会轻轻地按压臀部。这种支撑可以使患者迈出更大的步伐，不再僵硬，并提高活动能力和整体行走能力。

数位神经生物标记市场：分析概述

  • 根据类型，穿戴式装置占据市场主导地位，2024 年的收益占有率最大，为 39.9%。预计预测期内行动应用程式领域将以最快的复合年增长率成长。
  • 根据临床实践，诊断数位神经生物标记领域在 2024 年占据最大的市场占有率，超过 30%。预计监控部分在预测期内将呈现最快的复合年增长率。
  • 根据最终用途，医疗公司部门在 2024 年占据大部分份额，为 47.5%。预计医疗保健提供者部门在预测期内将呈现最快的复合年增长率。
  • 2024 年北美数位神经生物标记市场占据主导地位，收益占有率为 37.7%。诊断神经系统疾病的需求日益增长，导致对神经系统生物标记的需求显着增加。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章。

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 数位神经生物标记市场分析工具
    • 产业分析-波特五力分析
    • PESTEL 分析
    • 技术时间表和产品平臺分析
    • 案例研究分析/最终使用案例分析

第 4 章 数位神经生物标记市场：按类型估计和趋势分析

  • 细分仪表板
  • 数位神经生物标记物市场趋势分析（按类型）
  • 数位神经生物标记物市场展望（按类型）
  • 穿戴式装置
  • 基于行动的应用程式
  • 感应器
  • 其他的

第 5 章 数位神经生物标记市场：按临床程序进行的估计和趋势分析

  • 细分仪表板
  • 按临床程序进行的数位神经生物标记市场趋势分析
  • 按临床程序分類的数位神经生物标记物市场前景
  • 诊断数位神经生物磁铁
  • 用于监测的数位神经生物标记物
  • 用于预测和预后的数位神经生物标记物
  • 其他的

第 6 章：数位神经生物标记市场：按最终用途的估计和趋势分析

  • 细分仪表板
  • 数位神经生物标记市场趋势分析（按最终用途）
  • 数位神经生物标记物市场前景（按最终用途）
  • 医疗公司
  • 医疗保健提供者
  • 医疗保健付款人
  • 其他的

第七章 数位神经生物标记市场：区域估计与趋势分析

  • 区域控制面板
  • 数位神经生物标记市场趋势分析（按地区）
  • 数位神经生物标记市场：区域估计和趋势分析（按类型、临床程序和最终用途）
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Altoida Inc.
    • Koneksa
    • Biogen Inc.
    • Roche (Navify)
    • NeuraMetrix
    • Merck KGaA
    • Linus Health
    • Neurotrack Technologies, Inc.
    • Huma
    • NeuraLight
Product Code: GVR-4-68040-409-5

Digital Neuro Biomarkers Market Growth & Trends:

The global digital neuro biomarkers market size is anticipated to reach USD 2.82 billion in 2030 and is projected to grow at a CAGR of 25.7% from 2025 to 2030. The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population globally, advances in technology, demand for personalized medicine, and increased investment in the market by private and public players. Furthermore, positive regulatory approvals and increasing reimbursement coverage for digital health technologies encourage the adoption of digital neuro biomarkers. Regulatory bodies are recognizing the potential of these technologies to improve patient outcomes, leading to supportive policies and reimbursement models.

The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis is significantly fueling the demand for digital neuro biomarkers. These complex conditions necessitate accurate, continuous monitoring and early detection to manage symptoms effectively and improve patient outcomes. Digital neuro biomarkers, through advanced technologies such as wearable sensors and mobile health applications, offer precise tracking of neurological functions and disease progression. By providing real-time data and insights, these biomarkers enable early intervention and personalized treatment strategies, addressing the critical need for timely and targeted management of neurological conditions. For instance, in the U.S., close to 1 million individuals are impacted by multiple sclerosis (MS). Globally, it is estimated that over 2.8 million people are living with MS, according to the National Multiple Sclerosis Society. While most MS diagnoses occur between the ages of 20 and 50, the condition can affect individuals at any age. In addition, MS is more commonly diagnosed in women compared to men.

There is a growing emphasis on early detection and prevention of neurological diseases. Digital neuro biomarkers offer the advantage of detecting disease markers at an earlier stage than traditional methods, allowing for timely intervention and management. Integration of AI and machine learning is also driving the market growth, for instance, in September 2022, Nutromics secured USD 14 million in funding from Dexcom Ventures to advance its 'lab-in-a-patch' platform. This innovative technology utilizes DNA sensors to monitor a range of targets, including disease biomarkers and challenging-to-dose medications. Moreover, the integration of digital neuro biomarkers with broader digital health platforms, including electronic health records (EHRs) and telemedicine, enhances their utility and accessibility. This integration facilitates continuous monitoring and real-time data analysis, improving patient care and outcomes. For instance, In October 2021, Altoida, Inc., an AI company at developing advanced neurological disease diagnostics, launched a five-year multicenter observational study. This extensive study will involve thousands of patients across all stages of Alzheimer's disease, aiming to enhance the understanding and diagnostic capabilities of the disease continuum.

Key players are adopting various strategies to maintain a competitive edge such as mergers, acquisition, product launches, etc. Some of the key strategic initiatives by the major market players include:

  • In April 2024, Tris Pharma Inc. entered into a licensing agreement with Braingaze Ltd. and established Tris Digital Health. This new division will focus on the development and distribution of digital diagnostic and therapeutic products for attention-deficit/hyperactivity disorder (ADHD) and other neurological health conditions
  • In March 2024, Cumulus Neuroscience was awarded a grant of nearly USD 1.25 million from the Innovate UK SBRI (Small Business Research Initiative). This funding will support the development and validation of an AI diagnostic tool designed to enhance the accuracy of blood biomarkers. The new AI algorithms will integrate blood biomarkers with digital biomarkers-obtained through the Cumulus Neuroassessment Platform-and demographic information
  • In January 2024, Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences, Boston University Sargent College of Health & Rehabilitation Sciences, and the Wyss Institute at Harvard University developed a soft, wearable robot designed to assist individuals with Parkinson's disease in walking more smoothly. This innovative robotic garment, which is worn around the thighs and hips, provides a gentle push to the hips during each leg swing. This support helps the patient achieve a longer stride and reduces instances of freezing, improving mobility and overall walking ability

Digital Neuro Biomarkers Market Report Highlights:

  • Based on type, the wearable segment dominated the market with the largest revenue share of 39.9% in 2024. The mobile-based application segment is expected to witness the fastest CAGR over the forecast period.
  • Based on clinical practice, the diagnostic digital neuro biomarkers segment held the largest market share of over 30% in 2024. The monitoring segment is expected to witness at the fastest CAGR over the forecast period
  • Based on end use, the healthcare companies segment held the majority of share of 47.5% in 2024. The healthcare providers segment is expected to witness at the fastest CAGR over the forecast period
  • North America digital neuro biomarkers market dominated the market with a revenue share of 37.7% in 2024. The rising need for diagnosing neurological disorders has significantly increased the demand for neurological biomarkers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Clinical Practice
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Clinical practice outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Digital Neuro Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Digital Neuro Biomarkers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. Technology Timeline & Product Pipeline Analysis
    • 3.3.4. Case Study Analysis/ End Use Case Analysis

Chapter 4. Digital Neuro Biomarkers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Digital Neuro Biomarkers Market: Type Movement Analysis
  • 4.3. Digital Neuro Biomarkers Market by Type Outlook (USD Million)
  • 4.4. Wearables
    • 4.4.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Mobile based Applications
    • 4.5.1. Mobile based Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sensors
    • 4.6.1. Sensors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Digital Neuro Biomarkers Market: Clinical Practice Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Digital Neuro Biomarkers Market: Clinical Practice Movement Analysis
  • 5.3. Digital Neuro Biomarkers Market by Clinical Practice Outlook (USD Million)
  • 5.4. Diagnostic Digital Neuro Biomarkers
    • 5.4.1. Diagnostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Monitoring Digital Neuro Biomarkers
    • 5.5.1. Monitoring Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Predictive and Prognostic Digital Neuro Biomarkers
    • 5.6.1. Predictive and Prognostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Digital Neuro Biomarkers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Digital Neuro Biomarkers Market: End Use Movement Analysis
  • 6.3. Digital Neuro Biomarkers Market by End Use Outlook (USD Million)
  • 6.4. Healthcare companies
    • 6.4.1. Healthcare companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Healthcare Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Payers
    • 6.6.1. Payers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Digital Neuro Biomarkers Market movement analysis
  • 7.3. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis by Type, Clinical Practice & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Mexico Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. UK Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Germany Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. France Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Italy Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Spain Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Denmark Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Norway
      • 7.5.13.1. Norway Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Sweden
      • 7.5.14.1. Sweden Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Japan Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. China Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. India Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. South Korea Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Australia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Thailand Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Brazil Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Argentina Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. South Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Saudi Arabia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. UAE Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Kuwait Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Altoida Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Koneksa
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Biogen Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Roche (Navify)
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. NeuraMetrix
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merck KGaA
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Linus Health
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Neurotrack Technologies, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Huma
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. NeuraLight
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 5 Global digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 9 North America digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 12 U.S. digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 15 Canada digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 18 Mexico digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 22 Europe digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 24 UK digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 25 UK digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 27 Germany digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 28 Germany digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 30 France digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 31 France digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 34 Italy digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 37 Spain digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 40 Denmark digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 42 Norway digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 43 Norway digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Sweden digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 46 Sweden digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 China digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 51 China digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 52 China digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Japan digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 54 Japan digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 55 Japan digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 India digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 57 India digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 58 India digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 60 Australia digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 61 Australia digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 South Korea digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 63 South Korea digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 64 South Korea digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Thailand digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 66 Thailand digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 67 Thailand digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Latin America digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 69 Latin America digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 70 Latin America digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 71 Latin America digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Brazil digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 73 Brazil digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 74 Brazil digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Argentina digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 76 Argentina digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 77 Argentina digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 78 MEA digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 79 MEA digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 80 MEA digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 81 MEA digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Africa digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 84 South Africa digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 89 UAE digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 90 UAE digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 93 Kuwait digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Digital neuro biomarkers market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Digital neuro biomarkers market, type outlook key takeaways (USD Million)
  • Fig. 12 Digital neuro biomarkers market: type movement analysis 2024 & 2030 (USD Million)
  • Fig. 13 Wearable market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Mobile based applications market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Sensors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Digital neuro biomarkers market, clinical practice outlook key takeaways (USD Million)
  • Fig. 18 Digital neuro biomarkers market: clinical practice movement analysis 2024 & 2030 (USD Million)
  • Fig. 19 Diagnostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Monitoring psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Predictive and prognostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Digital neuro biomarkers market, end use outlook key takeaways (USD Million)
  • Fig. 24 Digital neuro biomarkers market: end use movement analysis 2024 & 2030 (USD Million)
  • Fig. 25 Healthcare companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Healthcare providers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Payers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Digital neuro biomarkers market: regional key takeaways (USD Million)
  • Fig. 30 Digital neuro biomarkers market: regional outlook, 2024 & 2030, USD Million
  • Fig. 31 North America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Norway Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 List of key emerging company's/technology disruptors/innovators